Brief: Essex Bio-Technology Says Unaudited Revenue Of Hk$438 Mln For Four Months Ended 30 April 2021
May 17 (Reuters) - Essex Bio-Technology Ltd 1061.HK :
* UNAUDITED REVENUE OF HK$438 MILLION FOR FOUR MONTHS ENDED
30
APRIL 2021
Source text for Eikon: ID:nHKSc3F5Tr
Further company coverage: 1061.HK
Recent news on Essex Bio-Technology
See all newsHong Kong's Essex Bio-Technology H1 revenue falls
Brief: Essex Bio-Technology Posts HY Profit Of HK$110.7 MLN
Brief: Essex Bio-Technology Expects 10% Revenue And 30% Profit Decrease For HY
Brief: Shanghai Henlius Biotech Says Phase 3 Study Of HLX04-O For WAMD Meets Primary Endpoint
Brief: Essex Bio-Technology Posts Final Dividend Of HK$0.07 Per Share